Company intelligence

Eloxx Pharmaceuticals

Biotech

Is this your company? Get featured or correct your listing →

Recent changes

  1. Sep 11, 2026IPO an undisclosed amount SEC EDGAR
  2. Sep 11, 2026Eloxx Pharmaceuticals Files To Uplist From OTC To Nasdaq Pulse story

Debt, IPO & other events

not counted in equity raised
DateEventAmountValuationInvestorsSource
Sep 11, 2026ipo——
SEC EDGAR

Latest Pulse

  1. Eloxx Pharmaceuticals Files To Uplist From OTC To NasdaqEloxx Pharmaceuticals filed an S-1 to uplist from the OTC Pink market to Nasdaq, offering 2.73 million shares plus pre-funded warrants at an assumed $10-12 per share to fund its rare-kidney-disease drug candidate.→

Coverage Timeline

newest first
  1. Sep 11, 2026IPOEloxx Pharmaceuticals Files To Uplist From OTC To Nasdaq→

All Coverage

IPO

Eloxx Pharmaceuticals Files To Uplist From OTC To Nasdaq

Illustration for: Eloxx Pharmaceuticals Files To Uplist From OTC To Nasdaq
IPO

Eloxx Pharmaceuticals Files To Uplist From OTC To Nasdaq

Eloxx Pharmaceuticals filed an S-1 to uplist from the OTC Pink market to Nasdaq, offering 2.73 million shares plus pre-funded warrants at an assumed $10-12 per share to fund its rare-kidney-disease drug candidate.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsIambic TherapeuticsAttovia TherapeuticsApnimedEli LillyRetension Pharmaceuticals
Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ·